• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Alleviant's Transcatheter Tech Obtains Breakthrough Status

    Signia Appoints New President

    At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities

    QT Imaging Signs Distribution Agreement With Freedom Ventures for Breast Scanner

    MedAcuity, Fathom Partner on Human Factors Engineering Services
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    PTI Engineered Plastics Inc.

    K-Tube Technologies

    Creganna Medical, part of TE Connectivity

    Medicoil

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Qosina Corp.

    Unicep

    Spectrum Plastics Group

    Concise Engineering

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    PAVmed Signs Letter of Intent With Case Western Reserve University to Commercialize EsoCheck Tech

    Five-minute, office-based alternative to endoscopy utilizes highly accurate DNA biomarkers to detect Barrett’s Esophagus.

    Related CONTENT
    • Self-Tuning Brain Implant Could Help Treat Parkinson's Patients
    • Vizient Launches Cybersecurity Task Force to Address Medical Device Safety
    • Engineer Develops 3D Printer that Can Create Complex Biological Tissues
    • Avedro Names Chief Business Officer
    • Calcium-Based MRI Sensor Increases Sensitivity of Brain Imaging
    Business Wire05.30.18
    PAVmed Inc., a multi-product medical device company, has signed a letter of intent with Case Western Reserve University to commercialize its EsoCheck technology.
     
    EsoCheck combines a non-invasive, cell-sampling device with highly accurate DNA biomarkers to detect Barrett’s Esophagus, the primary precursor of esophageal cancer. In a simple five-minute office-based test, the patient swallows a vitamin pill-sized capsule containing a small inflatable balloon attached to a thin catheter, which swabs the target area for cells as the catheter is withdrawn. The sample is then tested for the presence of DNA biomarkers recently shown to be highly accurate in detecting Barrett’s Esophagus.
     
    “We are very excited about the opportunity to work with the world-renowned Case Western Reserve faculty to commercialize this revolutionary technology,” said PAVmed Chairman and CEO Lishan Aklog, M.D. “Based on the results of a multicenter clinical study, recently published in a seminal article in Science Translational Medicine, we believe EsoCheck has the potential to replicate the impact of Pap screening for cervical cancer and colonoscopy screening for colon cancer in preventing deaths from esophageal cancer. Once consummated, this partnership will fulfill one of PAVmed’s central goals: to provide innovators and academic medical centers with a rapid, capital-efficient and streamlined pathway to commercialization of high-impact innovative products. By leveraging the substantial clinical work already completed by the team and interim results from an ongoing multicenter National Institutes of Health trial, we believe we can accelerate EsoCheck’s commercialization path and target the first quarter of 2019 for the launch of the first commercial product.”

    The incidence of esophageal adenocarcinoma (EAC), the most common cancer of the esophagus (the pipe through which food passes to the stomach), has quadrupled over the past 30 years. Its prognosis, however, remains dismal, with less than 20 percent of patients surviving five years.
     
    “The Case Western Reserve/University Hospitals team looks forward to consummating this partnership. We have been impressed by the PAVmed team’s track record of getting innovative products to market using a lean and efficient business model,” said Daniel I. Simon, M.D., president and chief academic officer of University Hospitals Cleveland Medical Center and professor of medicine at Case Western Reserve University School of Medicine. “Their unique and creative partnership model, which fully aligns our scientific and humanitarian interests with the commercial enterprise, is highly attractive to academic medical centers seeking to bring cutting-edge, life-saving technologies to patients.”
     
    The primary cause of EAC cancer is Gastroesophageal Reflux Disease (GERD), commonly known as chronic heartburn or acid reflux. GERD, where stomach acid refluxes into the esophagus, affects 20 percent to 40 percent of Western adult populations, according to published epidemiological data.
     
    The repeated exposure of the esophagus to acid can lead to pre-cancerous changes in its lining, called Barrett’s Esophagus. Nearly all patients diagnosed with EAC cancer have evidence of previously undetected Barrett’s Esophagus. If detected before EAC cancer develops, Barrett’s Esophagus can be successfully treated, usually with non-surgical approaches.
     
    “Our goal is to save lives through early detection,” said EsoCheck co-inventor Amitabh Chak, M.D., professor of medicine at Case Western University School of Medicine, gastroenterologist at UH Digestive Health Institute, and director of the Advanced Technology & Innovation Center of Excellence at University Hospitals Division of Gastroenterology and editorial board chair of Gastrointestinal Endoscopy, the pre-eminent journal in the field. “Heartburn symptoms, commonly seen in patients with acid reflux with or without Barrett’s, can easily be treated by over-the counter medications, while endoscopy, the standard diagnostic test, is expensive, invasive and requires sedation. As a result, wide screening for Barrett’s is not practical or cost-effective. We developed EsoCheck to provide the estimated 50 million at-risk patients a non-invasive, less costly test to detect Barrett’s and treat it before it turns deadly.”
     
    The EsoCheck kit includes a sampling device consisting of a vitamin pill-sized, silicone-covered capsule containing a small deflated balloon attached to a thin silicone catheter. The patient swallows the capsule and, once it reaches the stomach, the balloon is inflated with air. As the balloon is pulled back, it swabs the lower esophagus for cells. After a specified distance, the balloon is deflated so, in contrast to other esophageal sampling devices, the sample of cells is protected from dilution or contamination as it passes back through the upper esophagus and mouth.
     
    DNA is extracted from the cells and tested for a panel of DNA biomarkers developed by the laboratory of EsoCheck co-inventor Sanford Markowitz, M.D., Ph.D., the Ingalls Professor of Cancer Genetics medical oncologist at University Hospitals Seidman Cancer Center, NCI Outstanding Investigator Awardee, and head of the NIH-Case GI Cancers Program of Research Excellence (GI SPORE) and GI cancer genetics program at the Case Comprehensive Cancer Center.
     
    The Science Translational Medicine paper showed that DNA methylation of the VIM and CCNA1 genes is diagnostic of Barrett’s Esophagus and that EsoCheck, which combines the proprietary balloon sampling device with these biomarkers, was over 90 percent accurate at identifying patients without Barrett’s Esophagus. The third EsoCheck co-inventor, Joseph Willis, M.D., professor of pathology and pathology vice-chair for clinical affairs, at University Hospitals Cleveland Medical Center, is leading an ongoing NIH-supported effort to create a CLIA-certified VIM/CCNA1 DNA methylation test suitable for commercialization.
     
    Under terms outlined in the letter of intent, a PAVmed subsidiary and Case Western Reserve University propose to enter into a definitive license agreement in which the university will grant the subsidiary an exclusive worldwide license of the intellectual property rights for both the balloon sampling device and DNA biomarkers of EsoCheck.
     
    In return, Case Western Reserve will receive a non-cash license fee in the form of a minority equity interest in the subsidiary, with PAVmed retaining a supermajority equity interest. The agreement will be subject to certain regulatory and commercialization milestones, with the university receiving royalties based on revenue and a specified portion of any additional proceeds.
     
    The subsidiary will operate as a separate entity, raise its own capital and recruit a separate management team when deemed appropriate.
     
    The letter of intent does not constitute a binding contract and the proposed license will not be granted unless and until a definitive License Agreement has been executed by both parties.
     
    PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation. PAVmed’s pipeline of products address unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities. Its three lead products provide groundbreaking approaches to carpal tunnel syndrome (CarpX), vascular access (PortIO) and pediatric ear infections (DisappEAR). The company is also developing products in other areas, such as medical infusions and tissue ablation, while seeking to further expand its pipeline through engagements with clinician innovators and leading academic medical centers.
    Related Searches
    • non-invasive
    • patient
    • medical device
    • hospitals
    Suggested For You
    Self-Tuning Brain Implant Could Help Treat Parkinson Self-Tuning Brain Implant Could Help Treat Parkinson's Patients
     Vizient Launches Cybersecurity Task Force to Address Medical Device Safety Vizient Launches Cybersecurity Task Force to Address Medical Device Safety
    Engineer Develops 3D Printer that Can Create Complex Biological Tissues Engineer Develops 3D Printer that Can Create Complex Biological Tissues
    Avedro Names Chief Business Officer Avedro Names Chief Business Officer
    Calcium-Based MRI Sensor Increases Sensitivity of Brain Imaging Calcium-Based MRI Sensor Increases Sensitivity of Brain Imaging
    Wisdom Tooth: Electronic Sensor Checks Saliva to Screen for Disease Wisdom Tooth: Electronic Sensor Checks Saliva to Screen for Disease
    Business and Medical Leaders Join BioSig Technologies Advisory Board Business and Medical Leaders Join BioSig Technologies Advisory Board
    Microbot Medical to Acquire Novel Technology from CardioSert Microbot Medical to Acquire Novel Technology from CardioSert
    Early Stimulation Improves Performance of Bioengineered Human Heart Cells Early Stimulation Improves Performance of Bioengineered Human Heart Cells
    LimFlow Nominates Board Chairman and Expands Senior Management Team LimFlow Nominates Board Chairman and Expands Senior Management Team
    HIV Test Adapted to Develop Rapid Zika Virus Diagnostic Test HIV Test Adapted to Develop Rapid Zika Virus Diagnostic Test
    Advanced Bifurcation Systems Appoints Industry Veteran to Board of Directors Advanced Bifurcation Systems Appoints Industry Veteran to Board of Directors
    CRISPR-Based Tool Uses Paper Strips to Detect Genetic Signatures CRISPR-Based Tool Uses Paper Strips to Detect Genetic Signatures
    Viz.ai Announces Advisory Board Members, Signaling Leadership in Stroke Care Innovation Viz.ai Announces Advisory Board Members, Signaling Leadership in Stroke Care Innovation
    Ultrathin Needle Delivers Drugs Directly to the Brain Ultrathin Needle Delivers Drugs Directly to the Brain

    Related Breaking News

    • Cardiovascular
      Alleviant

      Alleviant's Transcatheter Tech Obtains Breakthrough Status

      The technology offers a no-implant interatrial shunt therapy for heart failure patients.
      Sam Brusco, Associate Editor 01.25.21

    • Signia Appoints New President

      Signia Appoints New President

      New executive most recently worked for Essilor of America.
      Michael Barbella 01.25.21

    • At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities

      At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities

      Public health officials need to stress the importance of mass testing and contact tracing even with several vaccines approved.
      Michael Barbella 01.25.21


    • QT Imaging Signs Distribution Agreement With Freedom Ventures for Breast Scanner

      QT Imaging Signs Distribution Agreement With Freedom Ventures for Breast Scanner

      Transmission ultrasound breast imaging now to become available in EMEA markets.
      Michael Barbella 01.25.21

    • MedAcuity, Fathom Partner on Human Factors Engineering Services

      MedAcuity, Fathom Partner on Human Factors Engineering Services

      Focused on facilitating safe and effective use of medical devices, HFE is a critical aspect of product development.
      Michael Barbella 01.25.21

    • Cretex Companies CEO Steps Down

      Cretex Companies CEO Steps Down

      Jeff Wollerman will succeed Lynn Schuler as CEO of the company.
      Charles Sternberg, Assistant Editor 01.22.21


    • Data Show Porex

      Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread

      Company initiates VFE testing for its porous polymer-based materials; results show components protect against certain aerosolized viruses.
      Michael Barbella 01.22.21

    • Endoscopic Hemostasis Devices Market Valued at $730 Million

      Endoscopic Hemostasis Devices Market Valued at $730 Million

      Value has driven by the recent approval of new devices.
      Michael Barbella 01.22.21

    • Henry Schein Buys Majority Interest in Prism Medical Products

      Henry Schein Buys Majority Interest in Prism Medical Products

      PRISM will operate as a subsidiary of Henry Schein Medical and will be managed separately as an individual division.
      Michael Barbella 01.22.21


    • Neurological
      Boston Scientific

      Boston Scientific's Vercise Genus DBS Earns FDA Approval

      Fourth-generation DBS portfolio features full-body MR conditional devices.
      Sam Brusco, Associate Editor 01.22.21

    • Biotech Team Develops ELISA Protocol for COVID-19 Antibody Detection

      Biotech Team Develops ELISA Protocol for COVID-19 Antibody Detection

      The new detection method can help determine whether patients have had COVID-19 and if they might still have immunity to the disease.
      Michael Barbella 01.22.21

    • TPI Partners with Zeiss

      TPI Partners with Zeiss

      Enables TPI to deliver 3D X-Ray Measurement capabilities for Quality Assurance for its clients.
      Charles Sternberg, Assistant Editor 01.21.21


    • Tubing & Extrusion
      PPE Moves into New Manufacturing Facility

      PPE Moves into New Manufacturing Facility

      New building is twice the size of the old one.
      Charles Sternberg, Assistant Editor 01.21.21

    • Neurent Medical Closes $25 Million Series B Financing

      Neurent Medical Closes $25 Million Series B Financing

      Supports the expansion of the company’s clinical and commercial operations.
      Charles Sternberg, Assistant Editor 01.21.21

    • Alcon Releases PRECISION1 for Astigmatism Contact Lenses in U.S.

      Alcon Releases PRECISION1 for Astigmatism Contact Lenses in U.S.

      The daily disposable, silicone hydrogel contact lens for astigmatism will roll out concurrently worldwide beginning in February.
      Sam Brusco, Associate Editor 01.21.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • Alleviant's Transcatheter Tech Obtains Breakthrough Status
    • Signia Appoints New President
    • At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    • QT Imaging Signs Distribution Agreement With Freedom Ventures for Breast Scanner
    • MedAcuity, Fathom Partner on Human Factors Engineering Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract
    Oleic Acid Possibly Implicated in MS Pathology
    NIH Study Compares Low-Fat, Plant-Based to Low-Carb, Animal-Based Diet
    Coatings World

    Latest Breaking News From Coatings World

    APV Engineered Coatings Reflects on 2020
    LINE-X Launches Dealer Program with International Truck
    BCF CEO to Chair Royal Society of Chemistry Surface Coatings Interest Group
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Alleviant's Transcatheter Tech Obtains Breakthrough Status
    Signia Appoints New President
    At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    Humanigen, Emergent Enter Covid-19 Partnership
    Samsung Bioepis Opens New Headquarters
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Fitglow Beauty Wins Big at Annual Dirty Thinker’s Choice Awards
    e.l.f. Cosmetics Unveils Mint Melt Collection
    Estée Lauder Companies Updates Supply Chain Leadership
    Happi

    Latest Breaking News From Happi

    Wellness Brand Partners with Kate Upton
    Curcumin's Role in Oral Care
    Degree Launches Bath and Shower Range
    Ink World

    Latest Breaking News From Ink World

    Paragon Expands Direct Mail Capabilities with Ricoh Pro VC70000
    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    VPF launches deep-freeze adhesive
    ProMach strengthens flexible packaging business
    Gallus planning virtual event for March
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Kimberly-Clark Releases Q4, Full Year Results
    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    First Patient Implanted With NEXXT MATRIXX SA Cervical Turn-Lock System
    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    First Solar Signs Definitive Agreement to Sell US Development Platform to Leeward
    Imec Technology Taking Off to Space
    Osram in Top 25 of World’s 100 Most Sustainable Companies

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login